Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
5.05
+0.13 (2.64%)
At close: Apr 10, 2026, 4:00 PM EDT
5.10
+0.05 (0.99%)
After-hours: Apr 10, 2026, 7:35 PM EDT
Q32 Bio Market Cap
Q32 Bio has a market cap or net worth of $73.88 million as of April 10, 2026. Its market cap has increased by 204.36% in one year.
Market Cap
73.88M
Enterprise Value
40.93M
1-Year Change
204.36%
Ranking
Category
Stock Price
$5.05
Market Cap Chart
Since March 26, 2024, Q32 Bio's market cap has decreased from $199.19M to $73.88M, a decrease of -62.91%. That is a compound annual growth rate of -38.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 73.88M | 80.85% |
| Dec 31, 2025 | 40.85M | -2.51% |
| Dec 31, 2024 | 41.90M | -78.96% |
| Mar 26, 2024 | 199.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rani Therapeutics Holdings | 82.88M |
| Filana Therapeutics | 82.12M |
| Estrella Immunopharma | 81.92M |
| Gossamer Bio | 81.53M |
| PolyPid | 80.72M |
| NeurAxis | 79.43M |
| Cognition Therapeutics | 78.65M |
| aTyr Pharma | 78.42M |